Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rocio Revello"'
Autor:
Diana Cuenca, Valeria Rolle, Katy de Paco Matallana, Nuria Valiño, Rocio Revello, Begoña Adiego, Manel Mendoza, Belen Santacruz, Maria del Mar Gil, Dandan Shi
Publikováno v:
Maternal-Fetal Medicine, Vol 3, Iss 2, Pp 100-106 (2021)
Abstract. Objective:. To determine the incidence of preeclampsia (PE) and preterm PE in Spain and to identify the risk factors for developing the disease. Methods:. This is a multicenter prospective cohort study performed at six maternity units acros
Externí odkaz:
https://doaj.org/article/1776cc4565934992887a7a89ecc3b3af
Autor:
Belén Santacruz, M. M. Gil, Valeria Rolle, Dandan Shi, Diana Cuenca, Begoña Adiego, Nuria Valiño, Manel Mendoza, Katy de Paco Matallana, Rocio Revello
Publikováno v:
Maternal-Fetal Medicine, Vol 3, Iss 2, Pp 100-106 (2021)
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Objective: To determine the incidence of preeclampsia (PE) and preterm PE in Spain and to identify the risk factors for developing the disease. Methods: This is a multicenter prospective cohort study performed at six maternity units across Spain. Wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633eb816cb22e897832a96546c10c299
https://hdl.handle.net/10641/2865
https://hdl.handle.net/10641/2865
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 47:705-711
OBJECTIVES First, to examine in twin pregnancies the performance of first-trimester screening for fetal trisomies 21, 18 and 13 by cell-free (cf) DNA testing of maternal blood and, second, to compare twin and singleton pregnancies regarding the distr
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 47:698-704
Objectives First, to report the distribution of the fetal fraction of cell-free (cf) DNA and the rate of a failed cfDNA test result in trisomies 21, 18 and 13, by comparison with pregnancies unaffected by these trisomies, second, to examine the possi
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 47:45-52
Objectives Cell-free DNA (cfDNA) analysis of maternal blood for detection of trisomies 21, 18 and 13 is superior to other methods of screening but is expensive. One strategy to maximize performance at reduced cost is to offer cfDNA testing contingent
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 29:2161-2165
To evaluate whether the amniotic fluid (AF) cytokine profile in women with chorioamnionitis may differentiate between those with and without funisitis.Forty women at high risk of chorioamnionitis were studied. Gestational age at study was 26.94. Amni
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 45:249-266
Objective To review clinical validation or implementation studies of maternal blood cell-free (cf) DNA analysis and define the performance of screening for fetal trisomies 21, 18 and 13 and sex chromosome aneuploidies. Methods Searches of PubMed, EMB
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 55, Iss 1, Pp 135-137 (2016)
We present a 32-year-old primigravida with no history of hereditary diseases or malformations in the family. The patient did not have any diseases. Her surgical history included an hysteroscopic myomectomy and a appendecectomy. The patient came to ou
Autor:
Bárbara Alonso-Luque, Jose L. Bartha, Mafalda Sousa E Faro Gomes, Rocio Revello, María Martin-Camean, Maria Jose Alcaide, Daniel Abehsera
Publikováno v:
The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 31(14)
First, to determinate the frequency of chorioamnionitis and funisitis in cases of intramniotic detection of Ureaplasma urealyticum. Second, to assess the predictive capability of some biological markers in the amniotic fluid of these women to predict
Publikováno v:
Journal of Lower Genital Tract Disease. 18:e66-e70
INTRODUCTION Gastrointestinal stromal tumors are very rare, representing 0.1% to 1% of gastrointestinal malignancies. Gastrointestinal stromal tumors outside the digestive tract comprise a very small fraction of all gastrointestinal stromal tumors, a